Sergio A. Rodriguez‐Aponte
Sergio A. Rodriguez‐Aponte publishes mostly in Molecular Biology, Infectious Diseases and Radiology, Nuclear Medicine and Imaging, on topics such as SARS-CoV-2 and COVID-19 Research, Monoclonal and Polyclonal Antibodies Research and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #2,037,482 of 7,710,434 ranked researchers
- Rank in United States
- #617,202 of 1,627,098
- Works
- 35
- Citations
- 676
- Citations per work
- 19.3
What does Sergio A. Rodriguez‐Aponte research?
Sergio A. Rodriguez‐Aponte's work is mostly in Biochemistry, Genetics and Molecular Biology (36%), Medicine (36%), Agricultural and Biological Sciences (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1645.9%
- Health Sciences1336.5%
- Medicine1336.5%
- Everything else617.6%
- 1Molecular Biology36% of their works
- 2Infectious Diseases24% of their works
- 3Radiology, Nuclear Medicine and Imaging8% of their works
- 4Animal Science and Zoology5% of their works
- 5Immunology4% of their works
- 6Cardiology and Cardiovascular Medicine4% of their works
Research topics
- SARS-CoV-2 and COVID-19 Research
- Monoclonal and Polyclonal Antibodies Research
- Viral Infectious Diseases and Gene Expression in Insects
- vaccines and immunoinformatics approaches
- Protein purification and stability
- Viral gastroenteritis research and epidemiology
- Animal Virus Infections Studies
- CRISPR and Genetic Engineering
Which keywords describe Sergio A. Rodriguez‐Aponte's research?
The keywords of their largest research topics: Vaccine, Coronavirus, Glycosylation, Monoclonal Antibodies, SARS-CoV-2, spike protein, Therapeutic Antibodies and Epidemiology.
- Porcine Reproductive and Respiratory Syndrome Virus
- Circovirus
- Protein Aggregation
- Biopharmaceuticals
- Peptide-MHC Binding
- Epitope Prediction
- Antibody Engineering
- Epidemiology
- Therapeutic Antibodies
- Monoclonal Antibodies
- Coronavirus
- Vaccine
- Glycosylation
- SARS-CoV-2
- spike protein
- Pathogenesis
- Fc Receptors
- Mammalian Cells
- Recombinant Protein
- Norovirus
- Rotavirus
- Genome Engineering
- RNA-Guided
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 23 words, with their numbers
- Vaccine253 topics
- Coronavirus192 topics
- Glycosylation152 topics
- Monoclonal Antibodies142 topics
- SARS-CoV-2141 topic
- Therapeutic Antibodies142 topics
- spike protein141 topic
- Epidemiology112 topics
- Pathogenesis112 topics
- Antibody Engineering81 topic
- Fc Receptors81 topic
- Epitope Prediction71 topic
- Mammalian Cells71 topic
- Peptide-MHC Binding71 topic
- Recombinant Protein71 topic
- Biopharmaceuticals61 topic
- Norovirus61 topic
- Protein Aggregation61 topic
- Rotavirus61 topic
- Circovirus51 topic
- Genome Engineering51 topic
- Porcine Reproductive and Respiratory Syndrome Virus51 topic
- RNA-Guided51 topic
Where does Sergio A. Rodriguez‐Aponte work?
Sergio A. Rodriguez‐Aponte's main affiliation in the publication record is Massachusetts Institute of Technology, United States.
How many publications and citations does Sergio A. Rodriguez‐Aponte have?
OpenAlex counts 35 works and 676 citations for Sergio A. Rodriguez‐Aponte, an h-index of 13, ranking #2,037,482 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sergio A. Rodriguez‐Aponte. Posts are plain text and can be reported.